BackTable Vascular and Interventional

🎬 Think your procedural tip could help others in the field? Submit it to the Tricks at the BackTable Competition! 👉 Winning videos will be featured on BackTable+, social media, and win exclusive BackTable gear. First 10 entries receive discount codes for 50% off in the…

🚨 Stroke care is evolving fast. Are you keeping up? Drs. Blaise Baxter & Jim Milburn join Dr. Michael Barraza to break down the latest in thrombectomy, large core & MVO trials (HERMES, BAOCHE), and why perfusion imaging may be on its way out. 🎙️ 🎧 Listen now:…

Hoping to fine tune your radiation segmentectomy? Take a listen to our newest episode of Dosimetry University with Drs. Tyler Sandow, Nima Kokabi, and Kavi Krishnasamy as they break down their technique of choice, optimal lesions to target, real world data, and case studies.…

How do you approach biliary endoscopy for gallstones? Sharpen your technique by hearing from expert @johnsmirnMD from @Georgetown_IR and host Dr. Michael Barraza as they discuss early experiences with cholangioscopy, technical advancements, challenges in treatment, choosing the…

Our understanding of RP1, an oncolytic virus used in the treatment of metastatic melanoma, is still evolving. Medical oncologist Dr. Sunandana Chandra and interventional radiologist Dr. Riad Salem review the current protocol for serial injections of RP1 in combination with…

How do experts balance aggressive tumor dosing with liver safety when treating HCC with Y90? Drs. Zach Berman & Tyler Sandow join Dr. Kavi Krishnasamy to break down real HCC cases, from large central tumors, portal vein invasion, and multifocal lesions. Tune in to glean insight…

How does a medical oncologist weigh different options for their patient’s liver-directed therapy, especially when randomized clinical trials are not available? Dr. Richard Finn discusses his viewpoints on safety and survival outcomes with transarterial chemoembolization (TACE),…

ICYMI:🧠Stroke care is evolving fast - are your interventions evolving with it? In this powerhouse episode, Dr. Michael Barraza is joined by neurointervention heavyweights Dr. Blaise Baxter (Sutter Health) and Dr. James Milburn (Ochsner Health) to dissect what today’s major…

How does a medical oncologist weigh different options for their patient’s liver-directed therapy, especially when randomized clinical trials are not available? Dr. Richard Finn discusses his viewpoints on safety and survival outcomes with transarterial chemoembolization (TACE),…

Less is more—at least when it comes to liquid embolics. Interventional radiologist Dr. Gary Siskin explains that using low volumes and injecting LAVA slowly allows for better control, improved cohesiveness between embolic particles, and a reduced risk of non-target embolization.…

How can interventional radiologists turn their clinical impact into revenue? In a conversation with host Dr. @bahetimd , Dr. Matt Hawkins—interventional radiologist and Health Policy & Economics Councilor at SIR—shares how IRs can prove and get paid for the value they bring to…

Transarterial chemoembolization (TACE) has been a cornerstone of treatment for intermediate-stage hepatocellular carcinoma (HCC) for over 30 years, undergoing several key evolutions during that time. Interventional radiologist Dr. Julius Chapiro discusses these developments,…

Transarterial chemoembolization (TACE) has been a cornerstone of treatment for intermediate-stage hepatocellular carcinoma (HCC) for over 30 years, undergoing several key evolutions during that time. Interventional radiologist Dr. Julius Chapiro discusses these developments,…

🚨Submission Window Extended! 🚨 We’re giving you more time to submit your best tricks for the BackTable Tricks Competition! If you haven’t sent yours in yet, now’s your chance to show off your skills and get featured. Stay tuned for the new deadline - and keep those…

Liquid embolics can be a life-saving tool to address traumatic hemorrhages in especially coagulopathic patients. Interventional radiologist Dr. Gary Siskin highlights benefits of liquid embolics over coils, including speed of embolization and high packing density. Stream the…

Do you have a protocol for post-procedural care and imaging after hepatic lesion ablation? @AsadBaigMD of @columbiaimaging shares his approach. Stream the full-length video episode: youtube.com/watch?v=X7WL0G… Thank you @Medtronic for supporting this episode. #VI528 #HCC #Cancer…

The ongoing IGNYTE-3 trial is investigating RP1, an oncolytic virus designed to target advanced melanoma. Dr. Riad Salem discusses the role of interventional oncology in this treatment approach, including identifying accessible lesions, optimizing injection techniques, planning…

What is the difference between “suspected” and “diagnostic” hepatocellular carcinoma (HCC), and how does this distinction affect treatment planning? Oncologist Dr. Richard Finn explains the circumstances under which treatment can begin for patients with a high suspicion of HCC,…

How do you determine which embolic material to use? Interventional radiologist Dr. Gary Siskin explains that several factors must be considered, including the distance between the catheter and the target embolization site, the size of the vessel, and the desired packing density.…

Tumor seeding, bleeding, and off-target ablation are potential risks associated with hepatic lesion ablation. @AsadBaigMD discusses strategies to minimize these risks and effective ways to communicate them to patients. Stream the full-length video episode:…

While immunotherapy for metastatic melanoma has resulted in impressively durable responses and prolonged survival, resistance to these treatments can occur. Medical oncologist Dr. Sunandana Chandra offers insight into alternative therapies, including targeted treatments,…